section name header

Solution Compatibility

Pembrolizumab

(Mfr: MSD)(Conc/L: 1 g)

C

Sodium chloride 0.9%

(Mfr: BRNa)

Remarks:

Physically and chemically stable for 7 days with in vitro PD-1 binding activity retained at 17 to 23°C or 2 to 8°C in light

Ref:

3878